Raffles Medical Group Ltd (SGX:BSL)
0.9450
-0.0050 (-0.53%)
May 28, 2026, 5:04 PM SGT
Raffles Medical Group Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Raffles Medical Group stock has a consensus rating of "Strong Buy" and an average price target of $1.22. The average 1-year stock price forecast is 29.10% higher than the current stock price, while the lowest is $1.02 (+7.94%) and the highest is $1.30 (+37.57%).
Price Target: $1.22 (+29.10%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 25, 2026.
Analyst Ratings
The average analyst rating for Raffles Medical Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Oct '25 | Nov '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Phillip Securities | Phillip Securities | Hold Maintains $1.02 | Hold | Maintains | $1.02 | +7.94% | Feb 25, 2026 |
| UOB Kay Hian | UOB Kay Hian | Buy Maintains $1.25 | Buy | Maintains | $1.25 | +32.28% | Feb 24, 2026 |
Unknown Analyst Lim & Tan Securities No rating | Lim & Tan Securities | Buy Maintains $1.20 | Buy | Maintains | $1.20 | +26.98% | Feb 23, 2026 |
| DBS | DBS | Buy Maintains $1.25 | Buy | Maintains | $1.25 | +32.28% | Feb 23, 2026 |
| CGS International | CGS International | Buy Reiterates $1.23 | Buy | Reiterates | $1.23 | +30.16% | Jan 6, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.